- Home
- IPW vs CODX Comparison
IPW vs CODX Comparison
Compare IPW & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- CODX
- Stock Information
- Founded
- IPW 2018
- CODX 2013
- Country
- IPW United States
- CODX United States
- Employees
- IPW N/A
- CODX N/A
- Industry
- IPW Catalog/Specialty Distribution
- CODX Medical/Dental Instruments
- Sector
- IPW Consumer Discretionary
- CODX Health Care
- Exchange
- IPW Nasdaq
- CODX Nasdaq
- Market Cap
- IPW 21.7M
- CODX 22.0M
- IPO Year
- IPW 2021
- CODX 2017
- Fundamental
- Price
- IPW $0.60
- CODX $0.71
- Analyst Decision
- IPW Strong Buy
- CODX Hold
- Analyst Count
- IPW 1
- CODX 1
- Target Price
- IPW $2.75
- CODX $1.50
- AVG Volume (30 Days)
- IPW 49.4K
- CODX 139.9K
- Earning Date
- IPW 02-13-2025
- CODX 03-13-2025
- Dividend Yield
- IPW N/A
- CODX N/A
- EPS Growth
- IPW N/A
- CODX N/A
- EPS
- IPW N/A
- CODX N/A
- Revenue
- IPW $80,844,081.00
- CODX $7,321,012.00
- Revenue This Year
- IPW $8.31
- CODX N/A
- Revenue Next Year
- IPW $77.15
- CODX N/A
- P/E Ratio
- IPW N/A
- CODX N/A
- Revenue Growth
- IPW N/A
- CODX 57.16
- 52 Week Low
- IPW $0.40
- CODX $0.65
- 52 Week High
- IPW $3.65
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- IPW 32.58
- CODX 43.93
- Support Level
- IPW $0.60
- CODX $0.69
- Resistance Level
- IPW $0.71
- CODX $0.73
- Average True Range (ATR)
- IPW 0.05
- CODX 0.04
- MACD
- IPW -0.00
- CODX 0.00
- Stochastic Oscillator
- IPW 1.10
- CODX 42.31
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.